Vanguard Group
SVRA icon

Vanguard Group’s Savara SVRA Stock Holding History

Vanguard Group’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$60.6M Buy
10,041,647
+1,728,453
+21% +$8.47M ﹤0.01% 2068
2025
Q3 		$29.7M Sell
8,313,194
-140,786
-2% -$416K ﹤0.01% 2426
2025
Q2 		$19.3M Buy
8,453,980
+334,733
+4% +$910K ﹤0.01% 2573
2025
Q1 		$22.5M Sell
8,119,247
-190,723
-2% -$527K ﹤0.01% 2456
2024
Q4 		$25.5M Buy
8,309,970
+365,959
+5% +$1.28M ﹤0.01% 2471
2024
Q3 		$33.7M Buy
7,944,011
+1,305,253
+20% +$5.76M ﹤0.01% 2353
2024
Q2 		$26.8M Buy
6,638,758
+575,138
+9% +$2.56M ﹤0.01% 2429
2024
Q1 		$30.2M Buy
6,063,620
+148,673
+3% +$718K ﹤0.01% 2393
2023
Q4 		$27.8M Buy
5,914,947
+150,346
+3% +$576K ﹤0.01% 2445
2023
Q3 		$21.8M Buy
5,764,601
+789,249
+16% +$2.81M ﹤0.01% 2510
2023
Q2 		$15.9M Buy
4,975,352
+248,679
+5% +$585K ﹤0.01% 2689
2023
Q1 		$9.22M Sell
4,726,673
-79,900
-2% -$180K ﹤0.01% 2980
2022
Q4 		$7.45M Buy
4,806,573
+1,527
+0% +$2.09K ﹤0.01% 3094
2022
Q3 		$7.45M Sell
4,805,046
-479
-0% -$771 ﹤0.01% 3098
2022
Q2 		$7.3M Sell
4,805,525
-13,699
-0.3% -$18K ﹤0.01% 3164
2022
Q1 		$6.31M Sell
4,819,224
-20,762
-0.4% -$25K ﹤0.01% 3409
2021
Q4 		$6M Buy
4,839,986
+347,739
+8% +$414K ﹤0.01% 3506
2021
Q3 		$6.2M Hold
4,492,247
– – ﹤0.01% 3519
2021
Q2 		$7.64M Buy
4,492,247
+1,078,960
+32% +$1.94M ﹤0.01% 3354
2021
Q1 		$7.1M Buy
3,413,287
+1,654,638
+94% +$2.83M ﹤0.01% 3349
2020
Q4 		$2.02M Buy
1,758,649
+21,712
+1% +$26.2K ﹤0.01% 3655
2020
Q3 		$1.89M Sell
1,736,937
-1,201
-0.1% -$2.06K ﹤0.01% 3502
2020
Q2 		$4.33M Buy
1,738,138
+362,165
+26% +$881K ﹤0.01% 3160
2020
Q1 		$2.92M Buy
1,375,973
+240,398
+21% +$659K ﹤0.01% 3190
2019
Q4 		$5.09M Buy
1,135,575
+60,908
+6% +$73.3K ﹤0.01% 3158
2019
Q3 		$2.85M Sell
1,074,667
-175,587
-14% -$439K ﹤0.01% 3330
2019
Q2 		$2.96M Buy
1,250,254
+10,794
+0.9% +$95.9K ﹤0.01% 3350
2019
Q1 		$9.13M Sell
1,239,460
-11,041
-0.9% -$83.2K ﹤0.01% 2876
2018
Q4 		$9.47M Buy
1,250,501
+4,261
+0.3% +$38.3K ﹤0.01% 2798
2018
Q3 		$13.9M Buy
1,246,240
+238,358
+24% +$2.74M ﹤0.01% 2756
2018
Q2 		$11.4M Buy
1,007,882
+124,486
+14% +$1.25M ﹤0.01% 2838
2018
Q1 		$8.13M Buy
883,396
+127,523
+17% +$1.5M ﹤0.01% 2931
2017
Q4 		$11.2M Buy
755,873
+350,325
+86% +$4.02M ﹤0.01% 2764
2017
Q3 		$3.79M Buy
405,548
+168,351
+71% +$1.09M ﹤0.01% 3214
2017
Q2 		$1.4M Buy
237,197
+177,339
+296% +$1.22M ﹤0.01% 3494
2017
Q1 		$518K Buy
59,858
+16,592
+38% +$143K ﹤0.01% 3750
2016
Q4 		$263K Sell
43,266
-64,630
-60% -$407K ﹤0.01% 3844
2016
Q3 		$830K Buy
107,896
+22,238
+26% +$631K ﹤0.01% 3630
2016
Q2 		$2.82M Buy
85,658
+13,193
+18% +$325K ﹤0.01% 3235
2016
Q1 		$1.39M Buy
72,465
+10,273
+17% +$237K ﹤0.01% 3496
2015
Q4 		$1.83M Buy
62,192
+3,531
+6% +$110K ﹤0.01% 3427
2015
Q3 		$2.38M Buy
58,661
+624
+1% +$19.9K ﹤0.01% 3293
2015
Q2 		$1.99M Buy
58,037
+5,250
+10% +$184K ﹤0.01% 3424
2015
Q1 		$1.79M Buy
52,787
+4,466
+9% +$155K ﹤0.01% 3453
2014
Q4 		$1.89M Buy
48,321
+8,167
+20% +$285K ﹤0.01% 3307
2014
Q3 		$1.57M Buy
40,154
+2,738
+7% +$115K ﹤0.01% 3362
2014
Q2 		$1.65M Buy
37,416
+127
+0.3% +$5.54K ﹤0.01% 3338
2014
Q1 		$1.77M Buy
37,289
+11,936
+47% +$654K ﹤0.01% 3277
2013
Q4 		$821K Sell
25,353
-21
-0.1% -$674 ﹤0.01% 3467
2013
Q3 		$780K Buy
25,374
+1,079
+4% +$33.5K ﹤0.01% 3434
2013
Q2 		$730K Buy
+24,295
New +$1.08M ﹤0.01% 3387

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group's SVRA Position: Q4 2025 in Review

Vanguard Group increased its Savara (SVRA) stake by 21% in Q4 2025, buying an estimated $8.47M and bringing the position to 10,041,647 shares worth $60.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

Vanguard Group first reported a position in SVRA in Q2 2013 and has held it in 51 quarters since. 147 funds tracked by Wall St. Rank hold SVRA as of Q4 2025.

  • Vanguard Group held 10,041,647 shares of Savara worth $60.6M as of Q4 2025.
  • Vanguard Group bought 1,728,453 Savara shares in Q4 2025, an estimated $8.47M.
  • Savara made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2068 holding.
  • Vanguard Group first reported a position in Savara in Q2 2013 and has held it in 51 quarters since.
  • 147 funds tracked by Wall St. Rank held Savara as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.